The angina drug ranozaline has been recommended to be listed on the PBS as add-on therapy for the symptomatic treatment of stable angina pectoris. At its March 2018 meeting the Pharmaceutical Benefits Advisory Committee (PBAC) recommended the Section 85 Authority Required (Telephone) listing of ranolazine. In its decision, the committee said there was an unmet ...
Ischaemic heart disease
PBS listings on the way for angina and FH drugs
27 Apr 2018